欢迎登录材料期刊网

材料期刊网

高级检索

简要介绍了生物降解聚合物聚β-羟基丁酸酯(PHB)的主要性能特点,着重评述了PHB在药物释放和组织工程方面的应用研究.并在药物释放方面介绍了利用PHB及其改性材料制成缓释微球作为药物缓释载体材料的研究;在组织工程方面综述了PHB在软骨、骨、心脏瓣膜等方面的应用研究进展.

参考文献

[1] 王梅 .聚合物(医用)腐蚀和降解机理[J].国外医学(生物医学工程分册),1997,20(02):117.
[2] 汤苏阳 .新型生物降解材料聚β-羟基丁酸酯生物相容性研究[D].西安:第四军医大学,1998.
[3] Gogole Wski S .Tissue response and in vivo degradation ofselected polyhydroxybutyrate: PLA, PHB,and PHB/VA[J].Journal of Biomedical Materials Research,1993,27(09):1135.
[4] Baptist J N .Augmentation of the rat mandible using guided tissue regeneration[J].Clinical Oral Implants Research,1994,5(02):75.
[5] Sandow J;Seidel H R .Microcapsule of regulatory peptides with controlled release:manufactureand injection preparation[P].EurPatAppl,172422,1985.
[6] Abe H;Yamamoto Y;Doi Y .Preparation of poly(3-hydroxybutyrate) microspheres containing lastet of an anticancer drug and its application to drug delivery systems[J].Kvbunshi Rvnshu,1992,19(01):61.
[7] Yamamto Y;Abe H;Doi et al.An experimental study on the releasing rate of poly (3-hydroxybutyrate) microsperes[J].Drug Delivery Systems,1992,7(05):367.
[8] Yamamto Y;Abe H;Doi et al.An experimental study on the releasing rate of poly (3-hydroxybutyrate) microsperes[J].Drug Delivery Systems,1993,8(02):131.
[9] Kawagachi T;Tsugane A;Higashide K .Control of drug release with a combination of prodrug and polymer matrix:antitumer activity and release profiles of 3′5′-diacyl-5-fluoro-2′-deoxyurkline from poly (3-hydroxybutyrate) microspheres[J].Journal of Polymer Science,1992,81(06):508.
[10] 赵景联,陈庆云,王云海,黄建新.PHB-PEG共混物为载体药物缓释微球的研究[J].西安交通大学学报,2001(07):759-763.
[11] 陈建海,陈志良,侯连兵,刘世霆.聚羟基丁酸酯缓释微球的制备与性能[J].功能高分子学报,2000(01):61-64.
[12] 陈建海,Washinton WC,陈志良,许重远.地西泮-聚羟基丁酸酯-羟基戊酸酯共聚物缓释微球制备与性质[J].中国药学杂志,2000(04):244-246.
[13] Korsatko N;Korsatko B;Lafferty R M.A study on the formulation and the release of terraceine from poly(3-hydroxybutyrate) microspheres[A].France,1987(01):243.
[14] Handjani R M;Ribier A .Topical pharmaceuticals and cos metics containing biodegradable nanoparticles for skin treatment[P].EurPatApplEP,447318,1991.
[15] Trau M;Truss R W .PHBV particles for controlled release of agrochemicals and pharmaceutics[P].EurPatApplEP,29317,1988.
[16] Langer R;Vacanti J P .Tissue Engineering[J].Science,1993,260(01):920.
[17] Edelman E R .Vascular tissue engineering designer arteries[J].Circulation Research,1999,85(12):1115.
[18] 杨维东,胡平,钱其春,高峰,张晓东,毛天球.应用聚羟基丁酸酯支架构建组织工程软骨[J].实用口腔医学杂志,2002(02):157-159.
[19] 欧国敏,包崇云,梁星,巢永烈,陈治清.聚羟基丁酸酯膜引导即刻植入种植体周围骨组织再生的研究[J].华西口腔医学杂志,2000(04):215-218.
[20] 史培良,胡平,顾晓明,高峰,杨维东,毛天球.聚羟基丁酸酯与骨髓基质细胞构建组织工程骨的实验研究[J].解放军医学杂志,2001(04):244-245.
[21] Boree N R;Dove J;Cooper J J et al.Development of a degradable composite for orthopaedic use :mechanical evaluation of a hydroxyapatite-polyhydroxybutyrate composite material[J].Biomaterials,1993,14(10):793.
[22] Doyle C;Tanner E T;Bonfield W .In vitro and in vivo evaluation of polyhydroxybutyrate and polydroxybutyrate reinforced with hydroxyapatite[J].Biomaterials,1991,12(11):841.
[23] Vacanti J P;Mayer J E;Langer R et al.Selection of biomaterials used in the construction of cardiac biopristheses[J].ANNALS OF THORACIC SURGERY,1995,60(01):513.
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%